A Non-Interventional, Multicenter, Prospective, Observational, Comparative Study to Understand Usage, Safety and Effect of TENeligliptin Vs. GLImepiride as an Add-on to METformin Treatment in Indian Type 2 Diabetes Patients - TENGLIMET

Torrent Pharmaceuticals Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

研究概览

暂无简介。

•1.Patient willing to provide informed consent
•2.Female or male patient aged 18 years or above
•3.Adult patients who had inadequately controlled type 2 diabetes mellitus despite using diet plus exercise and metformin:
•â??HbA1C: 7 to 9%
•â??FBG: >=140 mg/dL
•4.Physician prescribes teneligliptin or glimepiride as an add-on to metformin therapy
•5.Patients must provide written consent to use personal and/or health data prior to the entry into the study

•1.Patients with Type 1 diabetes mellitus
•2.Patient on antidiabetic therapy other than glimepiride, teneligliptin and metformin
•3.Contraindications for teneligliptin and glimepiride as per respective approved prescribing information
•4.Any reasons of medical and non-medical character, which in the opinion of the physician can prevent participant participation in the study
•5.Pregnant and lactating woman and women of child bearing potential not ready to use an effective barrier contraceptive method during the study

发起方

Torrent Pharmaceuticals Ltd